FORBES
RS Research was listed in among the most successful startups in Forbes’ 2025 Startup 50!
RS Research was listed in among the most successful startups in Forbes’ 2025 Startup 50!
RS Research was listed 13th in Fast Company’s 50 Most Innovative Companies 2024
RS Research has been selected to join the the inaugural cohort of prestigious Turcorn100 Program
RS Research has raised $12M in Series-A investment round with GEN Ilac as the lead investor
RS Research’s smart targeted drug candidate started phase-I clinical trial, recruiting patients